期刊文献+

52株非白色念珠菌对氟康唑和伊曲康唑的耐药分析 被引量:6

下载PDF
导出
摘要 目的调查我院非白色念珠菌(non-Candidaalbicans)对氟康唑和伊曲康唑的耐药特点,指导临床用药。方法用E-test法测定氟康唑和伊曲康唑对52株非白色念珠菌的最低抑菌浓度(MIC)。结果对52株非白色念珠菌氟康唑的耐药率为9.6%,MIC50/MIC90为3/16μg/ml;对伊曲康唑的耐药率为38.5%,MIC50/MIC90为0.5/2μg/ml。对52株非白色念珠菌2种药物抗菌活性总体一致性为34.6%(18/52),28株(53.8%)对伊曲康唑剂量依赖敏感,但仍对氟康唑敏感。结论非白色念珠菌对氟康唑和伊曲康唑表现不同程度耐药,应加强对非白色念珠菌耐药性的监控。
机构地区 深圳市人民医院
出处 《临床检验杂志》 CAS CSCD 北大核心 2005年第4期279-280,共2页 Chinese Journal of Clinical Laboratory Science
  • 相关文献

参考文献6

  • 1Rex J H, Rinaldi M G, Pfaller M A. Resistance of Candida species to fluconazole[J]. Antimicrob Agents Chemother,1995,39(1) :1-8.
  • 2Espinel-Ingroff A, Pfaller M A, Erwin M E, et al. Interlaboratory evaluation of Etest method for testing antifungal susceptibilities of pathogenic Yeasts to five antifungal agents by using casitone agar and solidified RPMI 1640 medium with 2% glucose [J]. J Clin Microbiol, 1996,34(4) :848-852.
  • 3Pfaller M A,Jones R N,Doern G V,et al. Bloodstream infections due to Candida species:SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998 [J]. Antimicrob Agents Chemother,2000,44(3) :747-751.
  • 4Safdar A, Chaturvedi V, Cross E W, et al. Prospective study of Candida species in patients at a comprehensive cancer center [J].Antimicrob Agents Chemother,2001,45 (7) :2129-2133.
  • 5Pfaller M A, Diekema D J, Messer S A, et al. In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood[J]. J Clin Microbio1,2003,41 (1) :78-83.
  • 6White T C, Marr K A, Bowden R A. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance [J]. Clin Microbiol Rev,1998,11 (4) :382-402.

同被引文献27

引证文献6

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部